FindTrial
Sign In

USEFULNESS OF ADVANCED MRI IN KNOWING SPREAD OF ENDOMETRIAL CANCER

Multiparametric MRI for prediction of aggressiveness of Endometrial Carcinoma. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055025
Enrollment
65
Registered
2023-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C541- Malignant neoplasm of endometrium

Interventions

None listed

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically suspicious cases of Endometrial Carcinoma Cases of Endometrial Carcinoma confirmed by histopathology

Exclusion criteria

Exclusion criteria: Subjects who had no satisfactory MRS voxel in lesions were excluded. Previous surgery or radiation to the pelvis. Previous malignancy other than endometrial carcinoma.

Design outcomes

Primary

MeasureTime frame
If positive correlation is found We will be able to non invasively predict the various aggressive features of endometrial carcinoma such as the type, grade & stage which will in turn help with the timely risk stratification, treatment planning & prognosisTimepoint: March, 2025—

Secondary

MeasureTime frame
Help with the timely risk stratification, treatment planning & prognosis of patients with endometrial carcinoma.Timepoint: March 2025—

Countries

India

Contacts

Public ContactDr Mahek Vachhani

Kasturba medical college, manipal

prakashini.k@manipal.edu9769176446

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026